Sapu003 in Advanced mTOR-sensitive Solid Tumors

Clinical trial NCT07369505 · RECRUITING

Trial details

NCT number: NCT07369505
Sponsor: SAPU NANO (US) LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Metastatic Renal Cell Carcinoma (RCC)Neuroendocrine Tumors Tuberous Sclerosis Complex (TSC)Hepatocellular Carcinoma (HCC)

Start date: 2025-12-15
Primary completion: 2026-06-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.